WHO WE ARE

INEX Innovate is Asia's first
molecular diagnostics company for women

INEX Innovate is constantly innovating to address valuable clinical unmet needs with diagnostic test offerings, and has developed a broad range of IP.

EXPANSION

Strategic expansion into growing markets

DEVELOPMENT

Development of robust
product pipeline

INNOVATION

Commitment to excellence in laboratory practice

OUR FOCUS

Improving women’s health through

innovative diagnostics

Our commitment to
innovation

INEX is dedicated to applying our R&D and proven commercial capabilities to address unmet needs in women’s and fetal health.
We develop solutions to some of the most prevalent women’s health challenges whilst ensuring equity and access to products.
INNOVATION
PROGRESS
SYNERGY
IP
67
PARTNERSHIPS
25
TEAM
53
ONGOING PROJECTS
4
THE DIFFERENCE

We are a research-driven company with focus on developing diagnostics platforms based on hard science. We work to deliver value to the most important stakeholder — the patient.

MAKING STRIDES

Global Footprint

Singapore
USA
China
United Kingdom
Hong Kong
Indonesia
India
Bangladesh
Myanmar
Malaysia
Thailand
INSIGHTS

Latest news

Announcements

𝘽𝙍𝙀𝘼𝙆𝙄𝙉𝙂 𝙉𝙀𝙒𝙎- 𝙄𝙉𝙀𝙓 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙚’𝙨 𝙊𝙫𝙖𝘾𝙞𝙨® 𝙤𝙗𝙩𝙖𝙞𝙣𝙚𝙙 𝙧𝙚𝙜𝙪𝙡𝙖𝙩𝙤𝙧𝙮 𝙖𝙥𝙥𝙧𝙤𝙫𝙖𝙡 𝙛𝙧𝙤𝙢 𝙃𝙚𝙖𝙡𝙩𝙝 𝙎𝙘𝙞𝙚𝙣𝙘𝙚 𝘼𝙪𝙩𝙝𝙤𝙧𝙞𝙩𝙮 (𝙃𝙎𝘼) 𝙎𝙞𝙣𝙜𝙖𝙥𝙤𝙧𝙚🎉 🇸🇬

Announcements

INEX Innovate Showcases Cutting-edge Medical Technologies at the 7th Annual Healthcare+ Expo in Taiwan! 🇹🇼🔬

Announcements

INEX Innovate proudly sponsors The INEX OSCAR Awards to recognize budding Clinician-Scientists in formal training programmes and celebrate those individuals who have made great progress with their research while in training. 🇸🇬

Announcements

BioSpectrum Asia features INEX Innovate’s announcement launch of epiHERA®, the company’s test for the Early Detection of Endometrial Cancer. 🇸🇬